Clinical Impact of Osimertinib Dose Reduction in the First-Line Setting on EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Monocentric Study

Iso H, Yomota M, Shirakura Y, Yoshinaga T, Kawai S, Narita K, Seike M, Hosomi Y

OncoTargets and Therapy 2025, 18:379-387

Published Date: 19 March 2025